Impact of pulmonary disease on patient-reported outcomes and patient-performed functional testing in systemic lupus erythematosus

Abstract

Objectives

This study examines the effect of pulmonary disease on patient-reported outcomes (PROs) and patient-performed outcome (PPO) in systemic lupus erythematosus (SLE) patients at a single tertiary referral center.

Methods

Pulmonary function tests (PFTs), chest imaging, SLE-related damage, and disease activity were examined in 110 SLE patients. Presence was noted of abnormal PFTs, pleural disease, pulmonary hypertension (PH), pulmonary infarction, interstitial lung disease (ILD), and shrinking lung syndrome (SLS). PROs included the Medical Outcome Short Form-36 Health Survey, Pittsburgh Sleep Quality Index, Fatigue Severity Scale, Borg Dyspnea Scale, patient dyspnea and cough. The PPO of interest was the six-minute walk test (6MWT). Relationships amongst PROs, 6MWT, and pulmonary disease were studied.

Results

Pulmonary disease was present in 62 (56%) of 110 subjects: 54 (49%) abnormal PFT, 13 (12%) pleural disease, 12 (11%) ILD, 11 (10%) SLS and five (5%) PH. Dyspnea was the only PRO found to be significantly associated with pulmonary disease (P = 0.0004). Participants with pulmonary disease compared to those without had significantly reduced distance (P = 0.00015, 95% CI for mean 39–125 m) and predicted distance (P = 0.00001, 10%–26%) on 6MWT.

Conclusions

Pulmonary disease is common in SLE and adversely impacts 6MWT distance and dyspnea without apparent influence on other PROs. The 6MWT may be a promising tool in the assessment of pulmonary disease in SLE.

Keywords

Lupus pulmonary disease six-minute walk test patient reported outcomes health-related quality of life

Get full access to this article

View all access options for this article.

References

Abu-Shakra

Mader

Langevitz

. Quality of life in systemic lupus erythematosus: a controlled study. J Rheumatol 1999; 26: 306–309.

Bernatsky

Boivin

Joseph

. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2550–2557.

Strand

Gladman

Isenberg

Petri

Smolen

Tugwell

. Endpoints: consensus recommendations from OMERACT IV. Outcome Measures in Rheumatology. Lupus 2000; 9: 322–327.

van Vollenhoven

Mosca

Bertsias

. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis 2014; 73: 958–967.

Mittoo

Fell

. Pulmonary manifestations of systemic lupus erythematosus. Semin Respir Crit Care Med 2014; 35: 249–254.

Hellman

Kirsch

Whiting-O'Keefe

. Dyspnea in ambulatory patients with SLE: prevalence, severity, and correlation with incremental exercise testing. J Rheumatol 1995; 22: 455–461.

Allen

Fischer

Bshouty

. Evaluating systemic lupus erythematosus patients for lung involvement. Lupus 2012; 21: 1316–1325.

Tan

Cohen

Fries

. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277.

Hochberg

. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725–1725.

10.

Statistics Canada. National Household Survey 2011, Ottawa: Statistics Canada, 2013.

11.

Bae

Koh

Chang

Kim

Park

Kim

. Reliability and validity of systemic lupus activity measure—revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus. Lupus 2001; 10: 405–409.

12.

Gladman

Ginzler

Goldsmith

. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363–369.

13.

Miller

Hankinson

Brusasco

. Standardisation of spirometry. Eur Respir J 2005; 26: 319–338.

14.

American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111–117.

15.

Borg

. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14: 377–381.

16.

Troosters

Gosselink

Decramer

. Six minute walking distance in healthy elderly subjects. Eur Respir J 1999; 14: 270–274.

17.

Cullen

Rodak

. Clinical utility of measures of breathlessness. Respir Care 2002; 47: 986–993.

18.

Hoffbrand

Beck

. ‘Unexplained’ dyspnoea and shrinking lungs in systemic lupus erythematosus. Brit Med J 1965; 1: 1273–1277.

19.

McHorney

Ware

Jr Lu

Sherbourne

. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994; 32: 40–66.

20.

Yang

. Validation and psychometric properties of Chinese version of SF-36 in patients with hypertension, coronary heart diseases, chronic gastritis and peptic ulcer. Int J Clin Pract 2012; 66: 991–998.

21.

Parshall

Mapel

Rice

Williams

O'Reilly

. Predictive validity of short-form health survey [36 items] scales for chronic obstructive pulmonary disease exacerbation. Heart Lung 2008; 37: 356–365.

22.

Chandrasekhara

Jayachandran

Rajasekhar

Thomas

Narsimulu

. The prevalence and associations of sleep disturbances in patients with systemic lupus erythematosus. Mod Rheumatol 2009; 19: 407–415.

23.

Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria for Fatigue. Measurement of fatigue in systemic lupus erythematosus: a systematic review. Arthritis Rheum 2007; 57: 1348–1357.

24.

R Core Team. R: A language and environment for statistical computing, Vienna: R Foundation for Statistical Computing, 2014. Available at: http://www.R-project.org/.

25.

Hothorn

Hornik

van de Wiel

Zeileis

. A Lego system for conditional inference. Am Stat 2006; 60: 257–263.

26.

Hothorn

Hornik

van de Wiel

Zeileis

. Implementing a class of permutation tests: the coin package. J Stats Softw 2008; 28: 1–23.

27.

Koenker R. quantreg: Quantile Regression. R package version 5.05, 2013. Available at: http://CRAN.R-project.org/package=quantreg.

28.

Venkatraman

Begg

. A distribution-free procedure for comparing receiver operating characteristic curves from a paired experiment. Biometrika 1996; 83: 835–848.

29.

Robin

Turck

Hainard

. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011; 12. 77. Available at: http://www.biomedcentral.com/1471-2105/12/77.

30.

Groen

ter Borg

Postma

Wouda

van der Mark

Kallenberg

. Pulmonary function in systemic lupus erythematosus is related to distinct clinical, serologic, and nailfold capillary patterns. Am J Med 1992; 93: 619–627.

31.

Bertoli

Vila

Apte

. Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage. Lupus 2007; 16: 410–417.

32.

Friedman

Alarcon

McGwin

Jr. . Systemic lupus erythematosus in three ethnic groups. IV. Factors associated with self-reported functional outcome in a large cohort study. LUMINA Study Group. Lupus in Minority Populations, Nature versus Nurture. Arthritis Care Res 1999; 12: 256–266.

33.

Urowitz

Gladman

Ibanez

. Changes in quality of life in the first 5 years of disease in a multicenter cohort of patients with systemic lupus erythematosus. Arthritis Care Res 2014; 66: 1374–1379.

34.

Hanly

Urowitz

Jackson

. SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus. Ann Rheum Dis 2011; 70: 961–967.

35.

Saketkoo

Mittoo

Huscher

. Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials. Thorax 2014; 69: 428–436.

36.

Ghaussy

Sibbitt

Jr Bankhurst

Qualls

. Cigarette smoking and disease activity in systemic lupus erythematosus. J Rheumatol 2003; 30: 1215–1221.

37.

Hudson

Hercz

Baron

Steele

. Cigarette smoking in patients with systemic sclerosis. Arthritis Rheum 2011; 63: 230–238.

38.

Ekblom-Kullberg

Kautiainen

Alha

Leirisalo-Repo

Miettinen

Julkunen

. Smoking, disease activity, permanent damage and dsDNA autoantibody production in patients with systemic lupus erythematosus. Rheumatol Int 2014; 34: 341–345.